Publisher Correction: Structural insights into binding specificity, efficacy and bias of a β<sub>2</sub>AR partial agonist
November 30th, 2018 by Matthieu Masureel
Publisher Correction: Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist
Publisher Correction: Structural insights into binding specificity, efficacy and bias of a β<sub>2</sub>AR partial agonist, Published online: 30 November 2018; doi:10.1038/s41589-018-0182-5
Publisher Correction: Structural insights into binding specificity, efficacy and bias of a β2AR partial agonistStructural insights into binding specificity, efficacy and bias of a β<sub>2</sub>AR partial agonist
October 16th, 2018 by Matthieu Masureel
Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist
Structural insights into binding specificity, efficacy and bias of a β<sub>2</sub>AR partial agonist, Published online: 16 October 2018; doi:10.1038/s41589-018-0145-x
The active-state structure of a GPCR occupied by a partial agonist, β2AR with salmeterol, together with mutagenesis and biophysical studies, explains this ligand's unusual pharmacological profile.Protonation drives the conformational switch in the multidrug transporter LmrP
December 8th, 2013 by Matthieu Masureel
Nature Chemical Biology 10, 149 (2014). doi:10.1038/nchembio.1408
Authors: Matthieu Masureel, Chloé Martens, Richard A Stein, Smriti Mishra, Jean-Marie Ruysschaert, Hassane S Mchaourab & Cédric Govaerts